Hamburg, February 20, 2020, altona Diagnostics GmbH, today announced the launch of the RealStar® SARS-CoV-2 RT-PCR Kit 1.0. The assay is based on real-time RT-PCR technology, for the detection of SARS-CoV-2 (previously 2019-nCoV) which is the causative agent of coronavirus disease 2019 (COVID-19).

Hamburg, February 07, 2019 altona Diagnostics GmbH, today announced the launch of the AltoStar® HCV RT-PCR Kit 1.5, an in vitro diagnostic test, based on real-time RT-PCR technology, for the detection and quantification of hepatitis C virus (HCV) specific RNA (genotypes 1 to 6). Read more

altona Diagnostics Brasil LTDA, São Paulo, the Brazilian subsidiary of the German infectious disease specialist altona Diagnostics GmbH (altona), Hamburg, got registration approval of ANVISA for its real-time PCR kit to detect RNA of Zika virus in human sample material.

altona Diagnostics celebrates the launch of the AltoStar® Molecular Diagnostic Workflow.The recently developed CE-IVD marked system will be shown at the ECCMID 2018 which will take place in Madrid, Spain, from 21 – 24 April 2018.

Together with our local partners we initiated a new cooperation project to contribute the process of integrating refugees. As first trainee Mustafa Abdulrazak Jadaa starts his medical technical assistant education in August.

On August 5, 2016, altona Diagnostics GmbH received Emergency Use Authorization (EUA) from the Korea Centers for Disease Control & Prevention (KCDC) for the RealStar® Zika Virus RT-PCR Kit 1.0.